Showing results (91-100 of 588) with videos related to

Sort By:
Pageof 59
Anticancer Research|April 12, 2015
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancerGiulia Pasello, Paolo Carli, Fabio Canova, et al.
British Journal of Cancer|March 10, 2022
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, et al.
Nuclear Medicine Communications|April 15, 2017
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patientsLaura Evangelista, Anna R Cervino, Silvia Michieletto, et al.
Clinical Lung Cancer|May 21, 2015
Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert PanelFilippo De Marinis, Emilio Bria, Paul Baas, et al.
International Journal of Molecular Sciences|August 22, 2018
Role of mTOR Signaling in Tumor Microenvironment: An OverviewFabiana Conciatori, Chiara Bazzichetto, Italia Falcone, et al.
NPJ Breast Cancer|February 4, 2023
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trialMaria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, et al.
Cancers|January 20, 2018
mTOR Cross-Talk in Cancer and Potential for Combination TherapyFabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Castration resistant prostate cancer (CRPC): state of the art, perspectives and new challengesFrancesco Massari, Francesca Maines, Alessandra Modena, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2015
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?Laura Evangelista, Anna Rita Cervino, Cristina Ghiotto, et al.
Annals of Surgical Oncology|January 10, 2015
Preoperative carboplatin-paclitaxel-bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be studyValentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, et al.
Pageof 59